Tognon, Germana
 Distribuzione geografica
Continente #
NA - Nord America 636
EU - Europa 169
AS - Asia 96
AF - Africa 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 907
Nazione #
US - Stati Uniti d'America 632
CN - Cina 68
DE - Germania 50
UA - Ucraina 39
IT - Italia 32
HK - Hong Kong 22
FI - Finlandia 15
IE - Irlanda 12
GB - Regno Unito 10
FR - Francia 5
CA - Canada 4
SG - Singapore 3
BE - Belgio 2
BR - Brasile 2
MU - Mauritius 2
AU - Australia 1
BG - Bulgaria 1
EU - Europa 1
IN - India 1
KR - Corea 1
LK - Sri Lanka 1
NL - Olanda 1
PT - Portogallo 1
SE - Svezia 1
Totale 907
Città #
Fairfield 91
Woodbridge 63
Chandler 61
Seattle 52
Cambridge 40
Houston 39
Ashburn 36
New York 36
Jacksonville 32
Wilmington 32
Dearborn 23
Hong Kong 22
Princeton 20
Brescia 16
Dublin 12
Helsinki 11
Shanghai 9
Ann Arbor 8
Jinan 8
Beijing 7
Nanjing 7
Shenyang 7
Changsha 5
Nanchang 5
Des Moines 4
Hangzhou 4
London 4
Los Angeles 4
Nardò 4
San Diego 3
Toronto 3
Brussels 2
Islington 2
Jiaxing 2
Kilburn 2
Kunming 2
Lanzhou 2
Leawood 2
Milan 2
Monmouth Junction 2
São Paulo 2
Almere Stad 1
Augusta 1
Aveiro 1
Borgo San Giacomo 1
Buccinasco 1
Colombo 1
Comun Nuovo 1
Falkenstein 1
Guangzhou 1
Gunzenhausen 1
Hebei 1
Hefei 1
Lappeenranta 1
Melbourne 1
Monsummano Terme 1
Mumbai 1
Ningbo 1
Orange 1
Pozzuoli 1
San Francisco 1
Sofia 1
Strasbourg 1
Taizhou 1
Tianjin 1
Wuhan 1
Zhengzhou 1
Totale 714
Nome #
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 146
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 139
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 134
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 110
Prognostic factors in early-stage ovarian cancer. 87
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 83
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 52
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 52
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 46
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 43
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes 21
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma 19
Totale 932
Categoria #
all - tutte 4.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.663


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201940 0 0 0 0 0 0 0 0 0 0 19 21
2019/2020205 26 6 4 18 13 30 37 24 13 25 0 9
2020/2021177 1 10 0 18 0 14 17 28 12 55 14 8
2021/2022112 15 18 0 1 0 4 12 5 4 16 12 25
2022/2023159 22 13 8 12 10 29 3 15 23 3 14 7
2023/2024132 7 6 17 10 6 40 7 7 23 7 2 0
Totale 932